Member Info for Retireby40

https://www.bbc.co.uk/news/amp/world-us-canada-54313110?__twitter_impression=true

A vaccine is highly unlikely to be readily available before next summer and most vaccines have circa 60% effectiveness and given say 50% will take it as it’s been rushed through testing will be needed for a long time.

Health care workers don’t die from the flu, flu doesn’t leave people breathless for months after and badly damage other organs. Therapies will also be very important. Both solutions (I think we should concentrate on wastewater) will be required long after Covid and can be used to detect other pathogens etc.

You’ve posted that numerous times. Please stop before you get reported. It’s boring.

I’m sure there’s a lot going on in the background and given how we have a decent on ground presence in China and are award winners as well as having product in many provinces I’m keen to see some pre-orders and that will then snowfall and FOMO. Remember China is massive and given what a hot topic wastewater monitoring is if they have the best solution all else will want the same and I suspect we could secure pre-orders from China ahead of anywhere else.

https://www.cnbc.com/amp/2020/09/25/hhs-wants-to-test-30percent-of-us-wastewater-for-the-coronavirus.html?__twitter_impression=true

The breathalyser sounds great and not just for COVID but well beyond, could be a game changer given the flexibility.

For me in the short term for shareholder value it’s about Microtrace OVA7100 and real-time monitoring. 3,000 will be retrofitted but surely the demand will be massive for water cos, govs May even insist they have it and put it into regulation. Massive opportunity and who else can do this?

I bet pre-orders from China will come soon and other countries. Demand will be massive and can we manufacture or do we need an OEMs for EU, Asia. America’s etc?

A massive opportunity and MWG already works in the US, China, Spain, India and has teams and partners all over.

Firstly some decent posts this morning and especially Lunsam.

I hope we get some news on water monitoring as although some may not think this big wastewater monitoring is still all over the media. There could’ve been so much more in the RNS and certainly presentation on this. Remember this MWG May RNS -

Simon Humphrey, CEO of Modern Water, commented:

"Following the 2019 launch in China of Modern Water's award winning Microtox LX laboratory water testing unit and the recent confirmation of the 10 industrial scale Microtox CTM units to be shipped in the 3rd quarter, yet another milestone order size and value for 20 of our new Microtrace PDV portable water contamination test units increases Modern Water's exposure to water health and safety in China.

"All Modern Water equipment require consumables and have the option to be upgraded with AI-As-A-Service offering predictive water contamination alerts based on accumulated historical data that may contribute to increased revenue per client."

I’m sure China would happily pre-order the real-time retrofits so announcing that would be good even when revenue will be realised in 2021 it shows quick monetisation and potential.

The predictive water contamination alerts is massive too yet we focussed on a breathalyser that’s months away and a good idea but there are many antigen tests with digital passports under validation right now.

Anyway, here’s hoping we get some positive news/info in the takeover doc but getting pre-orders of real-time units would be superb as what’s the plan once the 3,000 have been retrofitted? I imagine they will sell themselves but how can we scale up manufacturing?

I’m not selling any but am hopeful we get some tangible positive news on water monitoring. More articles are published all the time, it’s clearly a hot topic and sets us apart plus it’s proven with ecoli!

I think because the monitoring was known they wanted to spend more time on the breathalyser (not inhaler!) which was naive but I thought that at the time so am surprised someone on the BoD didn’t think the same.

You’ve got 4 rapid antigen tests being validated right now which we’re told look really promising. DVRG focusing on the breathalyser was a mistake, I get why but they’ve dropped the ball. Talking about a big reveal and only mentioning Dell in passing was also a mistake. I’m sure they can regain trust and there’s a lot of OTT talk but perhaps the quick change in sentiment will refocus them on monitoring although i doubt they need it.

A terrible end to the week but the fundamentals are good and this will bounce back and I’m sure once the takeover happens things will settle.

Gerry needs to rebuild trust with some holders. I still have faith and trust but many no longer do.

Computer I agree with your general sentiment and the wider market clearly does too. The test needed more explanation as it came from nowhere and to be fair the explanation wasn’t as clear as it should have been so posed more questions than answers.

The monitoring was kind of lost and took a back seat which was an error, no question. I guess because that was known they wanted to spend more time on the inhaler. It’s understandable and hindsight is wonderful but clearly a massive mistake. I feel sorry for many who for spiked but the fundamentals are better than they were although the focus should be on commercialising the real-time water monitoring and that’s where the emphasis should be.

There are many Rapid antigen tests being validated right now and we’ve not begun live virus testing yet so the market was understandably underwhelmed and has clearly spoken.

A missed opportunity re monitoring but the test could well have a large part to play but the market wanted to hear more on the monitoring plan.

Just catching up on posts but the 120% down is the best!

I’m a pedant and people who say I’m gonna give it 110% I think are dicks but 120% down is even better!

Not calling the author a dick BTW.

A shocking fall, no doubt but the fundamentals haven’t changed although perhaps the comms needs to. To be fair the reaction is massively OTT but they should’ve focussed on real-time monitoring and the test a bonus which should’ve had a less ambiguous explanation.

It’s clear now but hey, onwards and upwards. Holding long and strong

That’ll be the same for any self-administered test which is what’s needed for mass screening so a catch-22.

From yesterday please see MWG BB as I can’t be arsed to post on here too as so many QUs.

Q73: how does the chip find its way from my bathroom (if I just shaved per GB's example) to a chip scanner?
Put it in your pocket and drop by a scanner near you on your way to work
Q74: in the health and safety chain: who do you see owning chip scanners? are the scanners owned or leased?
They are owned and leased and subsidised depending on the footfall levels

Q65: Hi Gerry Still sat out here at anchor on Golden Princess with no passengers. Been six months now. When do we get it ?????? Captain ...... Roger
Hi Roger, You are on my mind regularly. We have the MicroTox PD units specifically designed for the five sludge tanks on your ship. We can't take samples on each floor, as we have to install them after the vacuums due to the low water content under pressure. We have to complete the 5,000 tests before the end of the year and we will have it ready for the Cruise industry early in 2021, which really is when your ship can take on first passengers. Thankfully the wastewater units can be retrofitted so nothing about heading back to port as each tank has isolation and still maintain mission critical state. Also, before you set off, the dormant water in the piping system will need to be flushed out due to the risk pathogens building up. I am sure your engineer has that on his list of things to do.
Q66: How long does the test take from blowing to getting a result?
under 30 seconds if done at the same time. However, you can take the test anywhere and just slot it into the scanner later and that takes about 20 seconds
Q67: The technology is in no doubt. Fabulous presentations by all. Thank you. Considering the collaborations involved and the scale required would DV have to consider joint venture proposals or are DV able to brand the 'whole system' under the DV name?
Microtox BT and Microtox PD are the names that will be at the front.
Q68: Are these devices patented, protected from replication from other companies?
Why would you now want every mass manufacturer producing them? Our AI, virus detection system is the IP
Q69: does this require any further testing ? If not when will it be available ?
This was a prototype presentation. Early 2021 before it is in the real-world environment
Q70: Have You Looked at Incorporating the Laser Reader into the breathalyser ?
For now, miniaturisation and battery technology would mean it would be the size of a DVD player in the old desktop, or maybe like the large 80's Mobile phones that looked like a brick
Q71: Have you looked at Adding a module to a Mobile phone to use as the Laser reader
Yes, this is a work in progress
Q72: How far is the collaboration with avacta gone to in terms of waste water
We signed a MoU with Avacta Group and Heads of Terms with Aptamer Group for a supply agreement, which was in the RNS yesterday morning

Q51: Can you share any aspirational daily sales / deep verge margin? In terms of conservative through to optimistic? PS. Well done :)
We just gave guidance for year-end 2020 which is £4m but no guidance on Microtox BT and wastewater Mictox PD units in 2021
Q52: Would you be working with WHO?
Possibly
Q53: Can the test distinguish between active and dead viral particles?
If you are breathing the virus out, you are highly infectious, therefore have a high viral load. That is what we are looking to detect.
Q54: How can you stop someone from using another persons test result
Why would you? Pub terrorist, to gain entry and infect everyone intentionally?
Q55: Will you need to raise further funds to speed up the development.
We don't now
Q56: How much interest have you received from commercial businesses?
lots
Q57: Thank you very much.
you're welcome
Q58: Why are the commercial agreements with Avacta and Aptamer non-exclusive?
Because the market is so vast, why would they want to work with a single partner?
Q59: Why only Aberdeen University for all of the validation testing?
Because they have a Containment Level 3 laboratory which can be used to test with the live SARS-CoV-2 virus and we have an agreement with them to do so, for us
Q60: What time scales are realistic for validation, scale-up and manufacturing/distribution?
Early 2021
Q61: Are the critical elements all IP protected either by you or by your partners?
Yes, for us we have 4 years of AI development in Rinocloud, 13 years of accumulated knowledge of working with virus and bacteria in Labskin and 30 years of detecting more than 2,700 contaminants in water and the accumulated data in Modern Water. But, on top of that proprietary heritage, this is about execution. Previous business expertise includes management creating a distribution channel in 300,000 drugstore outlets in 43 countries in under 18 months with 50 partners.
Q62: How many times will you be able to use each breathalyser?
Test microchip once, the breathalyser is your personal test unit, so you can use it every day
Q63: How many chips can be scanned at the same time in one machine? Where are the scanners located? What would the exact procedure be for 50,000 people going to, say, a football match?
make sure they test before heading to the stadium up to 18 hours before scanning their QR Code at the entrance to the stadium
Q64: How do we prove the test result is our own? Facial recognition in order to submit and again when presenting the QR code?
Your phone is registered with the Microtox BT App and our servers. No ID required. You purchase a pack of 5 tests and scan the code on the pack. These are now registered to your phone. When you do a single test, it is automatically scanned in the scanner and the Digital Health Pass is transmitted back to the registered phone with the App registered to the test just taken

Q39: From what you have said, does this mean that you have 100% specificity? Or could there be cross contanimation in the test unit? If there is the risk of cross contanimation, do you deal with false positives through a second test?
There is no reason you can test 3 times or 5 times as each test takes seconds. However In the video, we confirm that we detect at Femtogram level (0.000,000,000,000,010 the size of a grain of rice) per millilitre. Your breath can be examined in the 10's to 100's of femtograms per millilitre, so if you breathe virus onto the chip it is detected by the scanner. It is then compared to our datasets, which have samples of the target pathogen (in this case SARS-CoV-2) then it will be detected and you will be alerted instantly of a (positive for virus) so you are infectious.
Q40: What would it take to accelerate the pace?
It is already accelerating
Q41: how to the aptamer and the affirmer compare in insensitivity?
They both work for the purposes of what we are using them for
Q42: What manufacturing capacity do you have or expect on what timescale?
This has been considered from an engineering perspective, so all equipment is off the shelf components. Production of inhalers already exist and require exchange of injection moulds in multiple production lines with excess capacity around the globe. The same for the microchips. They are packaged using existing pharmaceutical production lines, again with massive excess capacity available around the world. Distribution channels and supply chain management are part of the project
Q43: How do you ensure the person with the Q code is the person who took the test?
Whoever scans the test when they purchase, that phone will be alerted and that phone will have the Digital Health Pass.
Q44: Microtox BT is trademarked to Azur Environmental..correct? If so - What IP do you have that protects against a larger company copying this and manufacturing?
Microtox is a registered trademark of Modern Water plc. Has been for decades
Q45: Can we please see a business model? In terms of margins? scalability? Timeline?
We do not provide forward statements such as this request in any public company
Q46: Once the breath sample has been taken via the inhaler, it appears the chip has to be read in a largish machine to get the result data into the digital phone app. So, how and where is it envisaged users of the inhaler will get their tests read by such a machine, and how much will such machines cost?
Think of ATM's. They will be everywhere and not cost the user anything to take a test. It will be built into the price of each test microchip that is purchased
Q47: Why has GB got a pair of horns?
Yeah, I saw that in the video and laughed myself
Q48: Lead time to market?
Early 2021
Q49: How will you make sure the government and media notices you?
They already do
Q50: Have you engaged with the UK govt / other govts, if so what was the response?
Yes, multiple Governments. The UK is only one a

Q28: Where do you see the testing machines being placed? Local centres in communities? Entrance of place people are looking to enter?
Everywhere similar to ATM availablilty
Q29: Hi all... well done on achievements! How will the manufacturing & scaling up of be funded
securitisation of future recurring revenues
Q30: The product suggests you need to be quite digitally savvy which could limit its mass appeal in society 1st world and 3rd world?
The biggest growth in the development world is in the use of digital smart phones.
Q31: What is the name of the Major global player?
Dell Technologies. They weer name checked in the Video at around minute 17
Q32: What is the installed base of the Micro tox units in a) The UK b) The EU c) The USA?
As ubiquitous as ATM's
Q33: WIll you be using both Aptamers and Affimers for the COVID test? Is one better than the other for this application?
Both can capture the Spike on the virus. Both work for the purposes of what we are using them for
Q34: What will be the approximate "one off" cost for the reusable breathalyser device? and what will be the cost for each test?
$25 (£20) for the breathalyser and $5 (£4) per test. Replacement saline solution dispenser units can be purchased in any drug store every 30 days for $4 (£3.50)
Q35: How many tests can each Microtox reader process per hour?
Initially at full rate 2 tests per minute. But this will increase with further automation where large quantities can be processed much faster. As I have mentioned, you do not need to stand beside the scanner to do your test, you can test before you arrive and just insert as each microchip is in a sealed unit once it is removed from the breathalyser..
Q36: What is the sensitivity and specificity of the Microtox BT?
In the video, we confirm that we detect at Femtogram level (0.000,000,000,000,010 the size of a grain of rice) per millilitre. Your breath can be examined in the 10's to 100's of femtograms per millilitre, so if you breathe virus onto the chip it is detected by the scanner. It is then compared to our datasets, which have samples of the target pathogen (in this case SARS-CoV-2) then it will be detected and you will be alerted instantly of a (positive for virus) so you are infectious.
Q37: Could you build the testing of multiple actors on the same test by using multiple binders in different parts of the chip? So flu and Covid-19?
That is covered in the Video by Nicola, our Head of Laboratory who confirms that we can build multiplex units. However, that will not be in the first iteration of the microchips. The scanners will be the exact same, just the chips will have multi-layers of Affimers/Aptamers and the datasets using AI will be for specific pathogens. This will likely increase process time by seconds, but a good way to detect whether you have viral or bacterial flu, COVID19, or just a cold
Q38: Does the device have a fail safe test - eg looking for other DNA to check that there has been a valid sample.

Q19: What is the % accuracy of COVID breathalyser and water detection system?
In the video, we confirm that we detect at Femtogram level (0.000,000,000,000,010 the size of a grain of rice) per millilitre. Your breath can be examined in the 10's to 100's of femtograms per millilitre, so if you breathe virus onto the chip it is detected by the scanner. It is then compared to our datasets, which have samples of the target pathogen (in this case SARS-CoV-2) then it will be detected and you will be alerted instantly of a (positive for virus) so you are infectious.
Q20: how much is the breathalyser to the public or would government pay for it?
Each test is expected to be less than or equal to $5 (about £4). Your personal hand-held unit costs about $25 (£20) Breathalyser which contains enough saline solution for about 1 month. This is replaceable for $4 (£3.50) and you may continue to use your Microtox BT unit with each test. It may or may not have government subsidy.
Q21: Has the Digital Pass been approved by U.K. Gov?
What was presented yesterday was a prototype and the App will form part of the trial process and although it can be used with any other rapid test equipment, we will not be releasing it until our initial 5,000 trial completes and we have fast-tracked CE Mark early in the New Year.
Q22: Where would a user be able to find the testers for the chips? Who is going to have them? Assume one would need to go to a 'testing centre' where the chips can be tested every day?
Scanning units will be available like ATM machines
Q23: what is the anticipated cost per test for each microtox BT test and how much of that would come back to DV?
We are negotiating revenue sharing so this is not yet known
Q24: will it detect influenza?
Currently, we only have sought Affimers and Aptamers. However, we can raise both binding agents to target any air-borne infectious disease, or be used as a diagnostic device, for something that can be transmitted by Breath. So although not part of this stage, influenza for viral or bacteria infection would be likely vailable simply by changing the binding agents on the chips and using alternative datasets for a speciic disease
Q25: We keep hearing about "false positives" with antibody testing... how accurate will we be?
They are so cheap, why would you not consider doing best of 3 or best of 5 if you think you have a false positive?
Q26: how would you mitigate the risk of transferring the virus to the box that does the analysis and other people/other slides?
They are sealed on removal from the breathalyser and opened inside the scanner. We already allow for particles in the air, so nothing escapes or is exposed to the elements outside of the breathalyser or the scanner
Q27: who operates the box that does the analysis?
You do not eve touch the scanner, infrared will open the unit for insertion and it will notice you inserting and take it, like a card at the ATM machine

Q9: Can the chip be multi sensitive, so covid plus metals?
The Microtrace OVA7100 units are being upgraded by removing the Voltameter and replacing with a laser scanner, their 100 micron filter will have an additional 10 micron filter added and the robotic arm, currently used to replace reagents for detection, will be used to swap in and out the nano-photonic plate with microchip on it. This is stage one and so will be an additional unit called a Microtox PD (Pathogen Detection). We will continue to miniaturise the existing modular electronics and look to reprogram the robotic arms to multi-task. For now they will be two separate pieces of equipment sold for their respective uses
Q10: Recycling of chips? Or at least reclamation of materials.
100% recycling built into the recovery, both for Health & Safety as the chips may (likely) have the virus, so automatically dropped into automated sealing plastic bags which are sealed before removal and shipped back for sterilisation and reuse
Q11: Cost of the reader device? Or expect that these are more centralised rather than home based.
Readers will initially be high cost but will be made available in public areas in a similar manner to vending machines/ATM's.
Q12: Someone else could breathe for you I suspect is the point.
Why?
Q13: Not a question, but congrats!
Appreciate the support
Q14: Can you confirm the data AI partner is Dell?
I can
Q15: Are the figures quoted re coatings confirmed or approximate? Are these going to be controlled in respect to copyright to avoid copies?
The nano-photonic microchips are blockchain identified. If they do not correspond to the chip ID on our server they will not be scanned and disposed of. Fake chips will not be able to be distributed. All chips are verified before use.
Q16: How are you avoiding copies / fakes?
The nano-photonic microchips are blockchain identified. If they do not correspond to the chip ID on our server they will not be scanned and disposed of. Fake chips will not be able to be distributed. All chips are verified before use.
Q17: Do we have an idea on the success rate for detection?
In the video we confirm that we detect at Femtogram level (0.000,000,000,000,010 the size of a grain of rice) per millilitre. Your breath can be examined in the 10's to 100's of femtograms per millilitre, so if you breathe virus onto the chip it is detected by the scanner. It is then compared to our datasets, which have samples of the target pathogen (in this case SARS-CoV-2) then it will be detected and you will be alerted instantly of a (positive for virus) so you are infectious.

Q1: Can you give an indication of when Deep Verge will be profitable?

From time to time the Company will provide guidance in revenues, but this remains a growth company and our last stated reference to funding was that we have sufficient to cover requirements well into 2021
Q2: Of multiple water testing units are to be installed across the world, how will this be funded going forward? I am expecting that the loan will not be enough to fund this?

We have indicated that with the funding in place and with additional funds from recent warrants the company is funded well into 2021.
Q3: The cash burn is a concern going forward even with the revenues generated so far in 2020. Can you address this Please. Are you confident Deep Verge will be able to handle the expenses and not Riley on another loan or placing?

We have indicated that with the funding in place and with additional funds from recent warrants the company is funded well into 2021.
Q4: Will Deepverge’s technologies for the identification of COVID-19 in waste water play an important role in allowing cruise ships, factories and offices to return to full capacity? Will it form part of the government’s ‘Moonshot’ and what are the timescales?

The Company is working with a consortium of partners that form part of many large scale projects on land and at sea. Our objective at the AGM is to outline a solution to open the economy.
Q5: Can we vote during the meeting?

The Company does value shareholder participation and values the votes of shareholders, so it encourages all Shareholders to exercise their voting rights by completing and submitting a proxy form. Please note that due to restricted attendance, the chairman of the meeting will be appointed as each Shareholder's proxy. The appointment of anyone other than the chairman of the AGM as a Shareholder's proxy will not be valid and will be deemed to be an appointment of the chairman of the AGM as that Shareholder's proxy.
Q6: What are the perceived barriers to market in delivering the end to end solution

Limited only by lack of cooperating and collaborative partners. The right sales, marketing and distribution channels achieve the necessary reach. The supply chain production partners in multiple territories and regulatory authorities supporting the use of the public use of the products and services
Q7: How do you plan to fund the requires expansion?

As you may have seen, our business model is based on a revenue share with partners, collaboration and cooperative parties. Over time these may be acquired for the benefit of all parties. Funding in the capital markets is the general means on which such undertaking are made.
Q8: Where will the chip reader be located

Everywhere
L